(Q40623573)

22 September 2017

title

Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma (English)

1 reference

22 September 2017

8

1 reference

22 September 2017

Chok Seng Chia

1

1 reference

22 September 2017

Kechen Ban

2

1 reference

22 September 2017

Hairuszah Ithnin

3

1 reference

22 September 2017

Harjit Singh

4

1 reference

22 September 2017

R Krishnan

5

1 reference

22 September 2017

Suryati Mokhtar

6

1 reference

22 September 2017

Nik Malihan

7

1 reference

22 September 2017

language of work or name

1 reference

1 December 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

84

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

163-172

1 reference

The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Cytokines in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

1 reference

7 January 2021

Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Tumor environment: a potent driving force in colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Chronic hepatitis B virus infection in Asian countries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Cloning of a new cytokine that induces IFN-gamma production by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Interleukin-18 regulates both Th1 and Th2 responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Control of tumor development by intratumoral cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

Increased interleukin-10 serum levels in patients with solid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900176-1

7 January 2021

10.1016/S0165-2478(02)00176-1

Identifiers

DOI

1 reference

22 September 2017

1 reference